Expression of MCM7,ER and PR in endometrial carcinomas

DENG Bo-ya,WANG Si-liang,LI Ai-lin,ZHANG Yi,HU Yan-jie,LI Lu,JIANG Yan-duo
DOI: https://doi.org/10.16695/j.cnki.1006-2947.2013.01.015
2013-01-01
Abstract:Objective To investigate minichromosome maintenance7(MCM7) expression in endometrial carcinoma and irs relationship with clinicopathological parameters. Methods The expression of MCM7 in cases of normal proliferative endometrium, atypical endometrial hyperplasia and endometrial carcinoma was measured by immunohistochemical analysis. The expression of estrogen receptor(ER) and progestogen receptor(PR) was measured by immunohistochemical staining. Results The expression level of MCM7 was increased in endometrial carcinoma than in atypical endometrial hyperplasia than in normal proliferative endometrium(P<0.05). In endometrial cancer, expression level of MCM7 was positively related to age (>45year, P=0.007), negatively related to the pathological differentiation degree(P=0.0003), and higher in ER and PR negative carcinoma tissues than in positive ones(P =0.002; P=0.021). Conclusion MCM7 might promote carcinogenesis and progress of endometrial carcinoma, especially in ER and PR negative endometrial carcinoma.
What problem does this paper attempt to address?